廣和通(300638.SZ)及子公司取得5項發明專利、2項實用新型專利、1項外觀設計專利證書
格隆匯9月15日丨廣和通(300638.SZ)公佈,公司及全資子公司西安廣和通軟件於近日收到中華人民共和國國家知識產權局頒發的8項專利證書。
其中5項發明專利證書為:寫卡方法、裝置、計算機設備和存儲介質;識別卡配置信息確定方法、裝置、計算機設備和存儲介質;數據連接方法、裝置、終端設備和計算機可讀存儲介質;多公網連接驅動方法、裝置、計算機設備和存儲介質;多模通信方法、裝置、網絡模塊和計算機可讀存儲介質。
2項實用新型專利證書為:一種温控電路及通訊設備;一種測試系統。
1項外觀設計專利證書為:無線通信模組。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.